12-27414903-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020183.6(BMAL2):​c.1587-966C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0895 in 151,880 control chromosomes in the GnomAD database, including 629 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.089 ( 629 hom., cov: 32)

Consequence

BMAL2
NM_020183.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.407

Publications

2 publications found
Variant links:
Genes affected
BMAL2 (HGNC:18984): (basic helix-loop-helix ARNT like 2) This gene encodes a basic helix-loop-helix transcription factor belonging to the PAS (PER, ARNT, SIM) superfamily. The PAS proteins play important roles in adaptation to low atmospheric and cellular oxygen levels, exposure to certain environmental pollutants, and diurnal oscillations in light and temperature. This protein forms a transcriptionally active heterodimer with the circadian CLOCK protein, the structurally related MOP4, and hypoxia-inducible factors, such as HIF1alpha. Consistent with its role as a biologically relevant partner of circadian and hypoxia factors, this protein is coexpressed in regions of the brain such as the thalamus, hypothalamus, and amygdala. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Oct 2011]
BMAL2-AS1 (HGNC:49892): (BMAL2 antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_020183.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.12 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020183.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BMAL2
NM_020183.6
MANE Select
c.1587-966C>G
intron
N/ANP_064568.3
BMAL2
NM_001394524.1
c.1620-966C>G
intron
N/ANP_001381453.1
BMAL2
NM_001394525.1
c.1578-966C>G
intron
N/ANP_001381454.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BMAL2
ENST00000266503.10
TSL:1 MANE Select
c.1587-966C>G
intron
N/AENSP00000266503.5Q8WYA1-1
BMAL2
ENST00000311001.9
TSL:1
c.1545-966C>G
intron
N/AENSP00000312247.5Q8WYA1-2
BMAL2
ENST00000395901.6
TSL:1
c.1476-966C>G
intron
N/AENSP00000379238.2Q8WYA1-3

Frequencies

GnomAD3 genomes
AF:
0.0892
AC:
13541
AN:
151762
Hom.:
616
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.111
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0611
Gnomad ASJ
AF:
0.0585
Gnomad EAS
AF:
0.118
Gnomad SAS
AF:
0.128
Gnomad FIN
AF:
0.0909
Gnomad MID
AF:
0.120
Gnomad NFE
AF:
0.0789
Gnomad OTH
AF:
0.0821
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0895
AC:
13588
AN:
151880
Hom.:
629
Cov.:
32
AF XY:
0.0905
AC XY:
6720
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.112
AC:
4644
AN:
41414
American (AMR)
AF:
0.0610
AC:
931
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0585
AC:
203
AN:
3472
East Asian (EAS)
AF:
0.117
AC:
607
AN:
5178
South Asian (SAS)
AF:
0.128
AC:
617
AN:
4810
European-Finnish (FIN)
AF:
0.0909
AC:
956
AN:
10522
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.0789
AC:
5356
AN:
67906
Other (OTH)
AF:
0.0821
AC:
173
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
639
1278
1916
2555
3194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0763
Hom.:
58
Bravo
AF:
0.0858
Asia WGS
AF:
0.121
AC:
420
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
7.6
DANN
Benign
0.83
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11049004;
hg19: chr12-27567836;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.